Literature DB >> 16813797

Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study.

Hashem B El-Serag1, Zhannat Nurgalieva, Rhonda F Souza, Chad Shaw, Gretchen Darlington.   

Abstract

BACKGROUND: The global gene expression in Barrett's esophagus (BE) in comparison to adjacent or histologically similar tissues has not been extensively studied.
OBJECTIVE: To test the feasibility of conducting gene arrays in endoscopically obtained mucosal specimens.
DESIGN: Cross-sectional feasibility study.
SETTING: The Houston Department of Veterans Affairs Medical Center. PATIENTS: We collected endoscopic biopsies from BE, normal esophagus, antrum, duodenum, and sigmoid colon from 5 patients with BE. RNA was extracted and subjected to cDNA microarrays and gene expression was compared between BE and control tissues. Reverse transcription-PCR was conducted to confirm some of the findings. MAIN OUTCOME MEASUREMENTS: Gene expression profiles in BE tissues and 4 control sites: squamous esophagus, antrum, duodenum, sigmoid colon.
RESULTS: On average, 2 biopsies by disposable jumbo biopsy forceps provided approximately 5 microg required for microarrays. From the original number of 22,283 gene probes, 13,805 genes had a quality score of P < .05 and were subjected to further comparison. BE gene expression clustered most closely with that of antrum and least closely with squamous esophagus. Of the 587 genes that had significantly different expression between BE and duodenum, 246 were upregulated and 341 were downregulated in BE. The expression of genes involved in apoptosis, negative regulation of apoptosis, and inflammatory response was significantly lower in BE compared to squamous esophagus. None of the gene groups were significantly overexpressed in BE compared to squamous esophagus or antrum. The reverse transcription-PCR confirmed the results of microarrays. LIMITATIONS: Small sample size.
CONCLUSIONS: Microarray-based studies are feasible in endoscopically obtained tissues. Differences in gene expression could identify potential markers and shed light on the pathogenesis of BE.

Entities:  

Mesh:

Year:  2006        PMID: 16813797     DOI: 10.1016/j.gie.2005.08.041

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.

Authors:  Jerzy Ostrowski; Michal Mikula; Jakub Karczmarski; Tymon Rubel; Lucjan S Wyrwicz; Piotr Bragoszewski; Pawel Gaj; Michal Dadlez; Eugeniusz Butruk; Jaroslaw Regula
Journal:  J Mol Med (Berl)       Date:  2007-03-30       Impact factor: 4.599

2.  Gene expression in Barrett's esophagus: laser capture versus whole tissue.

Authors:  Hashem B El-Serag; Zhannat Z Nurgalieva; Toni-Ann Mistretta; Milton J Finegold; Rhonda Souza; Susan Hilsenbeck; Chad Shaw; Gretchen Darlington
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

3.  Barrett's Esophagus: Emerging Knowledge and Management Strategies.

Authors:  Atul Bhardwaj; Thomas J McGarrity; Douglas B Stairs; Haresh Mani
Journal:  Patholog Res Int       Date:  2012-05-30

4.  Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment.

Authors:  Nir Modiano; Lauren B Gerson
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

5.  Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.

Authors:  Douglas B Stairs; Hiroshi Nakagawa; Andres Klein-Szanto; Shukriyyah D Mitchell; Debra G Silberg; John W Tobias; John P Lynch; Anil K Rustgi
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.